
|Articles|February 7, 2008
Merial drug adds claims
Previcox controls pain and inflammation.
Advertisement
Advertisement
Merial announced that the company has received FDA approval to expand the label claim for Previcox, a canine osteoarthritis pain reliever. The expanded label claim includes the control of postoperative pain and inflammation associated with soft-tissue surgery in dogs. For more, visit previcox.com.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on dvm360
1
Meet the 2026 Veterinary Heroes: David Brathwaite
2
Penn Vet launches One Health certificate to train cross-disciplinary health leaders
3
Study finds AI-enabled stethoscope falls short in diagnosing heart conditions in cats and dogs
4
Fromm Family Foods recalls two wet dog food pâtés over potential metal contamination
5







